Norio Chihara

11PUBLICATIONS
22CO-AUTHORS
Clinical pharmacology and therapeuticsTumour immunologyLearning analyticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Apr 24, 2026
Real-World Treatment Adherence and Persistence with C5 Inhibitor Therapy Versus Satralizumab in Patients with Neuromyelitis Optica Spectrum Disorder in Japan.

|Apr 02, 2026
Soluble TIM-3 and galectin-9 serve as additional diagnostic biomarkers in primary central nervous system lymphoma.

Shota Nishii, Ritsu Akatani, Kyoka Shiroma

|Aug 22, 2024
Live Streaming of the Professor's Ward Rounds in Undergraduate Neurology Education: Usability Study.

Kenji Sekiguchi, Seiji Kawano, Norio Chihara

|Jun 18, 2024
Interleukin-6 Signaling Blockade Induces Regulatory Plasmablasts in Neuromyelitis Optica Spectrum Disorder.

Ritsu Akatani, Norio Chihara, Atsushi Hara

|Jan 18, 2024
Efficacy and safety of mycophenolate mofetil for steroid reduction in neuromyelitis optica spectrum disorder: a prospective cohort study.

Ritsu Akatani, Norio Chihara, Shusuke Koto

|Oct 20, 2023
Long-term Effects of IL-6 Receptor Blockade Therapy on Regulatory Lymphocytes and Neutrophils in Neuromyelitis Optica Spectrum Disorder.

Takako Matsuoka, Manabu Araki, Youwei Lin

Pageof 2

Frequent Collaborators

5 joint publications

Riki Matsumoto

4 joint publications

Kenji Sekiguchi

2 joint publications

Ritsu Akatani

1 joint publications

Hiroaki Sekiya